Journal articles on the topic 'Radiotherapy quality assurance'

To see the other types of publications on this topic, follow the link: Radiotherapy quality assurance.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Radiotherapy quality assurance.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Kouloulias, V. E. "Quality assurance in radiotherapy." European Journal of Cancer 39, no. 4 (March 2003): 415–22. http://dx.doi.org/10.1016/s0959-8049(02)00461-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thwaites, David, Pierre Scalliet, Jan Willem Leer, and Jens Overgaard. "Quality assurance in radiotherapy." Radiotherapy and Oncology 35, no. 1 (April 1995): 61–73. http://dx.doi.org/10.1016/0167-8140(95)01549-v.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Vitale, Vito, Gerolama Buconte, Franca Foppiano, Paola Franzone, Marina Guenzi, Chiara Guglielmini, Marina Maione, and Gabriella Paoli. "Introducing Quality Assurance in Radiotherapy." Tumori Journal 84, no. 2 (March 1998): 101–3. http://dx.doi.org/10.1177/030089169808400203.

Full text
Abstract:
Introducing a Quality Assurance methodology appears particularly useful in Radiation Oncology due to the complexity of the procedures involved and the heterogeneity of the standards adopted, if any, in the great majority of the Centers. There are two possible ways of evaluating quality in the Health Environment: a formal, Institutional certification, or a voluntary one obtained through a mechanism of peer review. The European Society for Therapeutic Radiology and Oncology (ESTRO) started in 1994 with the publication of a methodological Report intended to be adopted by the individual national Societies, and this paper is an invitation to do it.
APA, Harvard, Vancouver, ISO, and other styles
4

Ikeda, H. "Quality Assurance Activities in Radiotherapy." Japanese Journal of Clinical Oncology 32, no. 12 (December 1, 2002): 493–96. http://dx.doi.org/10.1093/jjco/hyf116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bernier, J. "137 INVITED Quality Assurance of Radiotherapy." European Journal of Cancer 47 (September 2011): S34. http://dx.doi.org/10.1016/s0959-8049(11)70352-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Low, Daniel A. "Quality assurance of intensity-modulated radiotherapy." Seminars in Radiation Oncology 12, no. 3 (July 2002): 219–28. http://dx.doi.org/10.1053/srao.2002.33700.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Warrington, A. P., R. W. Laing, and M. Brada. "Quality assurance in fractionated stereotactic radiotherapy." Radiotherapy and Oncology 30, no. 3 (March 1994): 239–46. http://dx.doi.org/10.1016/0167-8140(94)90464-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kuten, A. "Quality assurance in breast cancer radiotherapy." European Journal of Cancer 29 (January 1993): S41. http://dx.doi.org/10.1016/0959-8049(93)90821-v.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Suharmono, Bambang Haris, Ika Yuni Anggraini, Hilmaniyya Hilmaniyya, and Suryani Dyah Astuti. "Quality Assurance (QA) Dan Quality Control (QC) Pada Instrumen Radioterapi Pesawat LINAC." Jurnal Biosains Pascasarjana 22, no. 2 (December 1, 2020): 73. http://dx.doi.org/10.20473/jbp.v22i2.2020.73-80.

Full text
Abstract:
Abstract LINAC is a radiotherapy instrument used to kill tumor and cancer cells in patients. To guarantee the quality of LINAC instruments, QA (Quality Assurance) is needed and to prove the quality assurance there is a need for QC (Quality Control). This is done also aims to examine and test data to determine standards and check the suitability of products to achieve maximum manufacturing operations or measures taken, namely to assess, maintain or improve the quality of treatment given. The role of medical physicists is very important because only medical physicists carry out the implementation of quality assurance of radiotherapy instruments. Keywords: Radiotherapy, Linear Accelerator, Quality Assurance, Quality Control AbstrakLINAC adalah instrumen radioterapi yang digunakan untuk mematikan sel tumor maupun kanker pada pasien. Untuk menjamin kualitas instrumen LINAC, maka diperlukan QA (Quality Assurance) dan untuk membuktikan adanya jaminan kualitas perlu QC (Quality Control). Hal ini dilakukan juga bertujuan untuk memeriksa dan menguji data untuk menentukan standar dan mengecek kesesuaian produk mencapai operasi manufaktur yang maksimum atau ukuran yang diambil yaitu untuk menilai, merawat atau memperbaiki kualitas perlakuan yang diberikan. Peran fisikawan medis sangat penting karena hanya fisikawan medis yang menjalankan pelaksanaan jaminan kualitas instrumen radioterapi. Kata kunci: Radioterapi, Linear Accelerator, Quality Assurance, Quality Control
APA, Harvard, Vancouver, ISO, and other styles
10

CAKIR, Aydin. "Quality assurance methods for intensity modulated radiotherapy." Turkish Journal of Oncology 28, no. 2 (2013): 81–90. http://dx.doi.org/10.5505/tjoncol.2013.568.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Wong, Victy Y. M. "Quality assurance devices for dynamic conformal radiotherapy." Journal of Applied Clinical Medical Physics 5, no. 1 (January 1, 2004): 8–15. http://dx.doi.org/10.1120/jacmp.26.145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Wong, Victy Y. W. "Quality assurance devices for dynamic conformal radiotherapy." Journal of Applied Clinical Medical Physics 5, no. 1 (May 25, 2004): 8–15. http://dx.doi.org/10.1120/jacmp.v5i1.1955.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Pawlicki, Todd, Matthew Whitaker, and Arthur L. Boyer. "Statistical process control for radiotherapy quality assurance." Medical Physics 32, no. 9 (August 22, 2005): 2777–86. http://dx.doi.org/10.1118/1.2001209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Perks, Julian, Ivan Rosenberg, and Jim Warrington. "Dose quality assurance for stereotactic radiotherapy treatments." Physics in Medicine and Biology 44, no. 10 (August 26, 1999): N209—N215. http://dx.doi.org/10.1088/0031-9155/44/10/401.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Horiot, J. C., J. Bernier, K. A. Johansson, E. van der Schueren, and H. Bartelink. "Minumum requirements for quality assurance in radiotherapy." Radiotherapy and Oncology 29, no. 2 (November 1993): 103–4. http://dx.doi.org/10.1016/0167-8140(93)90233-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Seelentage, Wolf, and Guido Garavaglia. "Minimum requirements for quality assurance in radiotherapy." Radiotherapy and Oncology 32, no. 2 (August 1994): 184. http://dx.doi.org/10.1016/0167-8140(94)90106-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Papanikolaou, Niko, and Daniel Saenz. "Quality assurance in MRI for radiotherapy planning." Physica Medica 32 (September 2016): 172. http://dx.doi.org/10.1016/j.ejmp.2016.07.271.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Glicksman, Arvin S., Frances Laurie, and Lawrence E. Reinstein. "Radiotherapy quality assurance in cooperative group trials." Controlled Clinical Trials 6, no. 3 (September 1985): 227. http://dx.doi.org/10.1016/0197-2456(85)90029-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Leer, J. W., A. McKenzie, P. Scalliet, and D. Thwaites. "The European quality assurance program in radiotherapy." European Journal of Cancer 33 (September 1997): S137. http://dx.doi.org/10.1016/s0959-8049(97)85165-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Morgan, Helen M. "Quality assurance of computer controlled radiotherapy treatments." British Journal of Radiology 65, no. 773 (May 1992): 409–16. http://dx.doi.org/10.1259/0007-1285-65-773-409.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Wiezorek, Tilo, Nico Banz, Michael Schwedas, Marcel Scheithauer, Henning Salz, Dietmar Georg, and Thomas G. Wendt. "Dosimetric Quality Assurance for Intensity–Modulated Radiotherapy." Strahlentherapie und Onkologie 181, no. 7 (July 2005): 468–74. http://dx.doi.org/10.1007/s00066-005-1381-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Pötter, R. "Quality assurance (QA) in pediatric radiotherapy (PR)." European Journal of Cancer 29 (January 1993): S26. http://dx.doi.org/10.1016/0959-8049(93)90735-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Miles, E., and K. Venables. "Radiotherapy Quality Assurance: Facilitation of Radiotherapy Research and Implementation of Technology." Clinical Oncology 24, no. 10 (December 2012): 710–12. http://dx.doi.org/10.1016/j.clon.2012.06.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Okamoto, Hiroyuki, Toshihiko Mochizuki, Kazutoshi Yokoyama, Akihisa Wakita, Satoshi Nakamura, Heihachi Ueki, Keiko Shiozawa, et al. "Development of Quality Assurance/Quality Control Web System in Radiotherapy." Japanese Journal of Radiological Technology 69, no. 12 (2013): 1405–11. http://dx.doi.org/10.6009/jjrt.2013_jsrt_69.12.1405.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Thiyagarajan, Rajesh, SujitNath Sinha, Ramamoorthy Ravichandran, Kothandaraman Samuvel, Girigesh Yadav, AshokKumar Sigamani, Vikraman Subramani, and Arunai Nambiraj. "Respiratory gated radiotherapy-pretreatment patient specific quality assurance." Journal of Medical Physics 41, no. 1 (2016): 65. http://dx.doi.org/10.4103/0971-6203.177279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Inoue, T. "Quality Assurance of Radiotherapy and its Clinical Assessment." Japanese Journal of Clinical Oncology 32, no. 12 (December 1, 2002): 497–505. http://dx.doi.org/10.1093/jjco/hyf115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Weber, D., C. Hurkmans, C. Melidis, V. Teglas, D. Lacombe, and V. Gregoire. "349 QUALITY ASSURANCE IN RADIOTHERAPY: THE EORTC EXPERIENCE." Radiotherapy and Oncology 102 (March 2012): S182—S183. http://dx.doi.org/10.1016/s0167-8140(12)70305-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Chang, David, Alisha Moore, Sylvia van Dyk, and Pearly Khaw. "Why quality assurance is necessary in gynecologic radiation oncology." International Journal of Gynecologic Cancer 32, no. 3 (March 2022): 402–6. http://dx.doi.org/10.1136/ijgc-2021-002534.

Full text
Abstract:
Quality assurance (QA) in radiation oncology involves all checks and processes that ensure that radiotherapy is delivered in an optimal and intended manner. QA is essential for the accurate delivery of brachytherapy and external beam radiotherapy in patients diagnosed with gynecologic malignancies. Inadequate QA can adversely impact clinical outcomes and reduce the reliability of clinical trials. This review highlights the importance of QA in gynecologic radiation oncology and explores the pertinent issues related to its implementation.
APA, Harvard, Vancouver, ISO, and other styles
29

Fraass, Benedick A. "Errors in Radiotherapy: Motivation for Development of New Radiotherapy Quality Assurance Paradigms." International Journal of Radiation Oncology*Biology*Physics 71, no. 1 (May 2008): S162—S165. http://dx.doi.org/10.1016/j.ijrobp.2007.05.090.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Chen, Yunsheng, Dionne M. Aleman, Thomas G. Purdie, and Chris McIntosh. "Understanding machine learning classifier decisions in automated radiotherapy quality assurance." Physics in Medicine & Biology 67, no. 2 (January 17, 2022): 025001. http://dx.doi.org/10.1088/1361-6560/ac3e0e.

Full text
Abstract:
Abstract The complexity of generating radiotherapy treatments demands a rigorous quality assurance (QA) process to ensure patient safety and to avoid clinically significant errors. Machine learning classifiers have been explored to augment the scope and efficiency of the traditional radiotherapy treatment planning QA process. However, one important gap in relying on classifiers for QA of radiotherapy treatment plans is the lack of understanding behind a specific classifier prediction. We develop explanation methods to understand the decisions of two automated QA classifiers: (1) a region of interest (ROI) segmentation/labeling classifier, and (2) a treatment plan acceptance classifier. For each classifier, a local interpretable model-agnostic explanation (LIME) framework and a novel adaption of team-based Shapley values framework are constructed. We test these methods in datasets for two radiotherapy treatment sites (prostate and breast), and demonstrate the importance of evaluating QA classifiers using interpretable machine learning approaches. We additionally develop a notion of explanation consistency to assess classifier performance. Our explanation method allows for easy visualization and human expert assessment of classifier decisions in radiotherapy QA. Notably, we find that our team-based Shapley approach is more consistent than LIME. The ability to explain and validate automated decision-making is critical in medical treatments. This analysis allows us to conclude that both QA classifiers are moderately trustworthy and can be used to confirm expert decisions, though the current QA classifiers should not be viewed as a replacement for the human QA process.
APA, Harvard, Vancouver, ISO, and other styles
31

Evans, Elin, Helen Mayles, Olivia Frances Naismith, Emma Hall, Alison Tree, John Staffurth, and Isabel Syndikus. "Pretrial outlining quality assurance in PIVITOLBoost." Journal of Clinical Oncology 37, no. 7_suppl (March 1, 2019): 50. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.50.

Full text
Abstract:
50 Background: PIVOTALBoost is a Phase III randomised controlled trial (CRUK/16/018) of radiotherapy to prostate and pelvic nodes versus prostate alone with or without prostate boost. To minimise impact of target volume delineation (TVD) variation on trial outcome, pre-trial radiotherapy quality assurance (RTQA) was implemented to identify and correct potential variations. Methods: Participating centres offering a prostate boost submitted two pre-accrual outlining benchmark cases: one with a central zone boost (GTVpb) only and another with GTVpb (peripheral zone), CTVp/psv and CTVn. A detailed outlining protocol and diagnostic information were provided to centres. Submitted outlines were compared to consensus volumes created by the trial management group (TMG). The TMG deemed the volumes acceptable or as having acceptable or unacceptable variation. Detailed feedback was provided for each submission. Unacceptable variations required resubmission. Results: 32 investigators submitted pre-trial outlines. GTVpb was the most incorrectly outlined volume; 22 (69%) outliners had unacceptable errors for case 2 GTVpb, 17 (53%) for case 1 GTVpb. Most common GTVpb error was inferior extent of lesion followed by incorrect lesion outlined. 12 (38%) of outliners had unacceptable errors for CTVp/psv, most commonly due to delineation at the prostate apex. 8 (25%) outliners had unacceptable CTVn mostly due to incorrect vessel delineation. Of 26 (81%) outliners required to resubmit at least 1 case, 3(12%) required a second resubmission due to unacceptable errors on first resubmission. Conclusions: The majority of pre-trial outlining submissions had unacceptable errors requiring resubmission of at least one case. This was predominantly due to boost delineation error which is a relatively new skill for prostate clinical oncologists in the UK. This suggests robust on-trial RTQA is imperative to minimise further variation. Clinical trial information: ISRCTN80146950.
APA, Harvard, Vancouver, ISO, and other styles
32

Baiotto, Barbara, Christian Bracco, Sara Bresciani, Antonella Mastantuoni, Pietro Gabriele, and Michele Stasi. "Quality Assurance of a Record-and-Verify System." Tumori Journal 95, no. 4 (July 2009): 467–72. http://dx.doi.org/10.1177/030089160909500410.

Full text
Abstract:
Aims and background With the introduction of more complex three-dimensional conformal radiotherapy and intensity-modulated radiotherapy techniques in clinical practice, the use of record-and-verify systems is recommended to improve the accuracy of radiotherapy treatments. The aim of the present study was to evaluate, for a commercial record-and-verify system, the efficiency, integration with the treatment planning system, and impact of manual checking of data. The most frequent errors or misses were also evaluated. Materials and methods The development of internal protocols to systematically implement new technologies has been identified as a priority in the departmental quality assurance process. Data electronically fed into the record-and-verify system were compared with those manually recorded in the clinical paper chart over a period of almost 6 years (October 2000 to December 2006). A total of 7768 treated patients was reviewed. The check was performed by using a homemade data base in which the errors are stratified as follows: 1) general section, 2) geometric and dosimetric section, and 3) delivered dose section. Results On a total of 7768 checked patients, one or more mismatches between treatment planning system data and record-and-verify system data or paper chart data were observed for 452 patients (5.8% of total number of inspected patients). The percentage of discrepancies out of the total was: 2.2% in the general section, 3.3% in the dosimetric and geometric section, and 4.2% in the delivered-dose section. Conclusions Although record-and-verify systems assume a crucial role in the accuracy and reproducibility of radiation treatment, their inability to eradicate all the errors requires vigilance on the part of the radiation therapy and physics team.
APA, Harvard, Vancouver, ISO, and other styles
33

Kim, Jeong-Ho, Gha-Jung Kim, Se-Jong Yoo, and Ki-Jin Kim. "Reliability estimation about quality assurance method of radiotherapy planning." Journal of the Korea Safety Management and Science 17, no. 1 (March 31, 2015): 119–24. http://dx.doi.org/10.12812/ksms.2015.17.1.119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Goodman, K. A. "Quality Assurance for Radiotherapy: A Priority for Clinical Trials." JNCI Journal of the National Cancer Institute 105, no. 6 (March 6, 2013): 376–77. http://dx.doi.org/10.1093/jnci/djt031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Heeren, Germaine. "Education, science and quality assurance in radiotherapy in Europe." Reports of Practical Oncology & Radiotherapy 7, no. 1 (2002): 7–9. http://dx.doi.org/10.1016/s1507-1367(02)70974-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

FRANCO, L., F. GOMEZ, A. IGLESIAS, R. LOBATO, J. MARIN, J. MOSQUERA, J. PARDO, A. PAZOS, J. PENA, and M. POMBAR. "A 128 pixel linear array for radiotherapy quality assurance☆." Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 535, no. 1-2 (December 11, 2004): 98–101. http://dx.doi.org/10.1016/s0168-9002(04)01581-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Melidis, C., W. R. Bosch, J. Izewska, E. Fidarova, S. Ishikura, D. Followill, J. Galvin, A. Haworth, T. Kron, and C. W. Hurkmans. "EP-1434 QUALITY ASSURANCE FOR CLINICAL TRIALS IN RADIOTHERAPY." Radiotherapy and Oncology 103 (May 2012): S546—S547. http://dx.doi.org/10.1016/s0167-8140(12)71767-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Abbott, N., G. W. Jones, P. Parsons, D. G. Lewis, E. Spezi, M. Kaur, L. Magill, R. Gray, S. P. Bach, and D. Sebag Montefiore. "EP-1918: Radiotherapy quality assurance in the TREC trial." Radiotherapy and Oncology 119 (April 2016): S910. http://dx.doi.org/10.1016/s0167-8140(16)33169-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Rosenzweig, Douglas P., Michael C. Schell, and Yuji Numaguchi. "Quality assurance in linac-based stereotactic radiosurgery and radiotherapy." Medical Dosimetry 23, no. 3 (September 1998): 147–51. http://dx.doi.org/10.1016/s0958-3947(98)00020-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Bulski, Wojciech, Krzysztof Chełmiński, Piotr Ulkowski, Wioletta Ślusarczyk-Kacprzyk, Iwona Grabska, and Paweł Kukołowicz. "The role of SSDL in quality assurance in radiotherapy." Reports of Practical Oncology & Radiotherapy 25, no. 6 (November 2020): 902–5. http://dx.doi.org/10.1016/j.rpor.2020.08.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Ling, C. Clifton, Pengpeng Zhang, Yves Archambault, Jiri Bocanek, Grace Tang, and Thomas LoSasso. "Commissioning and Quality Assurance of RapidArc Radiotherapy Delivery System." International Journal of Radiation Oncology*Biology*Physics 72, no. 2 (October 2008): 575–81. http://dx.doi.org/10.1016/j.ijrobp.2008.05.060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Franco, L., F. Gómez, A. Iglesias, R. Lobato, J. Marín, J. Mosquera, J. Pardo, et al. "A 128 pixel linear array for radiotherapy quality assurance." Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 535, no. 1-2 (December 2004): 98–101. http://dx.doi.org/10.1016/j.nima.2004.07.115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Seaby, A. W., and M. Thomas. "Two-dimensional kinetic models for radiotherapy planning quality assurance." British Journal of Radiology 72, no. 854 (February 1999): 193–95. http://dx.doi.org/10.1259/bjr.72.854.10365072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Samuel, R., E. Thomas, D. Gilson, and R. J. D. Prestwich. "Quality Assurance Peer Review for Radiotherapy for Haematological Malignancies." Clinical Oncology 31, no. 10 (October 2019): e1-e8. http://dx.doi.org/10.1016/j.clon.2019.06.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Dharmarajan, Kavita V., Debra L. Friedman, T. J. FitzGerald, Kathleen M. McCarten, Louis S. Constine, Lu Chen, Sandy K. Kessel, et al. "Radiotherapy Quality Assurance Report From Children's Oncology Group AHOD0031." International Journal of Radiation Oncology*Biology*Physics 91, no. 5 (April 2015): 1065–71. http://dx.doi.org/10.1016/j.ijrobp.2014.11.034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Kesteloot, Katrien, André Dutreix, and Emmanuel van der Schueren. "Quality Assurance Procedures in Radiotherapy: Economic Criteria to Support Decision Making." International Journal of Technology Assessment in Health Care 9, no. 2 (1993): 274–85. http://dx.doi.org/10.1017/s0266462300004499.

Full text
Abstract:
AbstractThis paper details the costs of two types of quality assurance activities in radiotherapy: in vivo dosimetry, intended to check the delivered dose, and portal imaging to check the treated volume. For both activities, either on-line or off-line techniques may be used. Describing the costs allows the calculation of which techniques are most COSt-efficient for different radiotherapy departments.
APA, Harvard, Vancouver, ISO, and other styles
47

Yang, S. W., M. J. Han, D. H. Lee, and S. K. Park. "Feasibility study of perovskite film dosimeter for radiotherapy quality assurance." Journal of Instrumentation 17, no. 09 (September 1, 2022): P09038. http://dx.doi.org/10.1088/1748-0221/17/09/p09038.

Full text
Abstract:
Abstract In this study, we developed a film-type perovskite dosimeter that can be used as a radiotherapy quality assurance (QA) dosimeter while replacing the existing semiconductor dosimeter. Dosimeter performance was evaluated by reproducibility, linearity, dose rate dependence, and percentage depth dose (PDD). In terms of reproducibility, the relative standard deviation (RSD) at 6 MV and 15 MV energy were 1.058% and 1.003%, respectively. As a result of linearity, a coefficient of determination of 0.9999 was presented at 6 MV and 15 MV energies. In terms of dose rate dependence evaluation, the RSD was 1.242% and 0.628% at 6 MV and 15 MV energies, respectively. As for PDD measurement, the result of matching the Dmax point was obtained. Our analysis confirms that the perovskite film dosimeter made of CsPbBr3 was suitable for use as a QA dosimeter in radiotherapy.
APA, Harvard, Vancouver, ISO, and other styles
48

Balli, M., V. D. Ferrari, F. Lonardi, G. Pavanato, A. De Lucchi, and M. Coeli. "Benefits to be expected from informatics in Radiotherapy." Urologia Journal 61, no. 1 (February 1994): 63–68. http://dx.doi.org/10.1177/039156039406100114.

Full text
Abstract:
The role of informatics in radiotherapy planning concerns dose calculation, dose distribution and quality assurance. Software research has recently developed to obtain 3-dimensional planning of treated volume and to reach more homogeneous dose distribution within radiation target volume. To increase therapeutic effectiveness, lower local relapses and reduce treatment sequelae, several quality assurance systems are being used, such as portal image analysis which allows an immediate comparison with the simulation film. Such procedures are carried out through informatics and need state-of-the-art computed systems, dedicated radiological devices and highly qualified teams as well.
APA, Harvard, Vancouver, ISO, and other styles
49

Gonashvili, T., K. Kotetishvili, and G. Gavashelishvili. "DIFFERENCE BETWEEN RADIOTHERAPY QUALITY ASSURANCE DEVICES (ARC- AND MAP-CHECKS)." European Chemical Bulletin 8, no. 2 (April 11, 2019): 51. http://dx.doi.org/10.17628/ecb.2019.8.51-56.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Khaw, P., V. Do, K. Lim, J. Cunninghame, J. Dixon, J. Vassie, M. Bailey, et al. "Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial." Clinical Oncology 34, no. 3 (March 2022): 198–204. http://dx.doi.org/10.1016/j.clon.2021.11.015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography